CRISPR Gene Editing Therapies: 2024 FDA Approval, Challenges of Affordability, Marketing, and Ethical Considerations
2024: The Dawn of CRISPR Gene-Editing Therapies and the Challenges of Affordability, Marketing, and Ethical Considerations In 2024, the medical world took a groundbreaking leap forward as the Food and…